Pancreatic Cancer Research

ResearcherNorthern Jiangsu People's HospitalActive in the last 2 years

Daorong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1642-0889; OpenAlex author ID A5074788913. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 4 papers · 2023: 1 paper · 2024: 1 paper

Papers 14

  1. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review. Co-author DOI 10.1016/j.ijbiomac.2024.130149↗
  2. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.216031↗
  3. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. Co-author DOI 10.1111/imm.13496↗
  4. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Co-author DOI 10.1186/s12964-021-00806-y↗
  5. Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Co-author DOI 10.1186/s12964-021-00808-w↗
  6. Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14225475↗
  7. CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-217476/v1↗
  8. Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.783617↗
  9. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway. Last author DOI 10.3892/or.2018.6202↗
  10. PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway. Last author DOI 10.18632/oncotarget.21212↗
  11. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer. Co-author DOI 10.1007/s13277-015-3233-5↗
  12. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0090476↗
  13. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. First author DOI 10.1002/ijc.27715↗
  14. Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.mehy.2013.03.027↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Tang · 10 shared papers, 2013–2024 · strength 1.63
  2. Huan Zhang · 5 shared papers, 2021–2022 · strength 0.85
  3. Wenjie Zhang · 4 shared papers, 2021–2024 · strength 0.76
  4. Gengyu Sha · 3 shared papers, 2022–2024 · strength 0.68
  5. Zhilin Zhang · 3 shared papers, 2021–2023 · strength 0.58
  6. Zhengting Jiang · 2 shared papers, 2022–2024 · strength 0.46
  7. Zhongxu Yuan · 5 shared papers, 2013–2018 · strength 0.24
  8. Zhengting Jiang · 1 shared paper, 2023 · strength 0.22
  9. Lin Shi · 1 shared paper, 2022 · strength 0.20
  10. Dong Tang · 4 shared papers, 2013–2017 · strength 0.17
  11. Ying Tian · 2 shared papers, 2017–2018 · strength 0.13
  12. Yi Miao · 3 shared papers, 2013–2015 · strength 0.12
  13. Kuirong Jiang · 3 shared papers, 2013–2015 · strength 0.12
  14. Jun Gao · 2 shared papers, 2014–2015 · strength 0.08
  15. Chuanqi Xu · 1 shared paper, 2015 · strength 0.04
  16. Hui Chen · 1 shared paper, 2013 · strength 0.04
  17. Chuanli Ren · 1 shared paper, 2013 · strength 0.04
  18. Zipeng Lu · 1 shared paper, 2013 · strength 0.03
  19. Yong An · 1 shared paper, 2013 · strength 0.03
  20. Xiaofeng Xue · 1 shared paper, 2013 · strength 0.03
  21. Jian‐Min Chen · 1 shared paper, 2013 · strength 0.03
  22. Jishu Wei · 1 shared paper, 2013 · strength 0.03
  23. Min Tu · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.